Optimal first‐line treatment for advanced thymic carcinoma
Background Thymic carcinomas (TCs) are rare aggressive tumors with no standard first‐line treatment. This study was conducted to determine the optimal chemotherapy regimen for advanced TC. Methods This retrospective study included 67 patients treated for stage IV TC in 2006–2015. The primary endpoin...
Main Authors: | Xue Yang, Minglei Zhuo, Anhui Shi, Shengnan Yang, Ziping Wang, Meina Wu, Tongtong An, Yuyan Wang, Jianjie Li, Jia Zhong, Hanxiao Chen, Bo Jia, Zhi Dong, Jun Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-11-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.13181 |
Similar Items
-
Chemotherapy and prognosis in advanced thymic carcinoma patients
by: Zhengbo Song, et al.
Published: (2015-12-01) -
Thymic Squamous Cell Carcinoma: A Population-Based Surveillance, Epidemiology, and End Result Analysis
by: Xudong Yang, et al.
Published: (2020-12-01) -
Optimal management of thymic malignancies: current perspectives
by: Drevet G, et al.
Published: (2019-07-01) -
Evaluation of Surgical Therapy in Advanced Thymic Tumors
by: Till Markowiak, et al.
Published: (2021-09-01) -
Chemotherapy in the treatment of thymic tumors
by: Marcello Tiseo, et al.
Published: (2011-12-01)